Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Northwest Biotherapeutics Strengthens Board Capability

Northwest Biotherapeutics (NW Bio), a biotechnology company developing personalised immunotherapy products based in Bethesda, Maryland, has appointed Susan Bayh and Cofer Black as independent directors.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

eFFECTOR Therapeutics Secures New Series B Funding

eFFECTOR Therapeutics, an early-stage company focused on the discovery and development of small molecule cancer therapeutics in San Diego, has secured its Series B financing up to USD 56 million. The new funding came from Sectoral Asset Management, a new investor in the syndicate, as well as existing investors. Meanwhile, eFFECTOR Therapeutics appointed Maha Katabi, a partner from Sectoral, to its board of directors.

Read the full article…

Posted in M&A Finance and Funding | Tagged , , , , , , , , , , , , | Leave a comment

PsiOxus Therapeutics Elects Paolo Paoletti as Chairman of the Board

PsiOxus Therapeutics, an immuno-oncology company in Oxford, England, has appointed Paolo Paoletti to Chairman of its Board to replace Michael Moore. Moore will remain on the Board as Deputy Chairman.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , , , | Leave a comment

Scott Morrison Nets Two Board Appointments

Scott Morrison, a retired Ernst & Young Partner, was appointed to the board of directors at Audentes Therapeutics and Global Blood Therapeutics.Watch Full Movie Online Streaming Online and Download

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

Idera Pharmaceuticals Elects Maxine Gowen to Board of Directors

Idera Pharmaceuticals, a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, has appointed Maxine Gowen to its board of directors.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

Rodin Adds Samantha Singer to Board of Directors

Rodin Therapeutics, a biotechnology company developing therapeutics for neurological disorders based in Cambridge, Mass, has appointed Samantha Singer as an independent member of the company’s board of directors. Singer is COO of the Broad Institute of MIT and Harvard, where she oversees the institute’s human resources, finance, facilities, and information technology teams, in addition to the Office of Strategic Alliances and Partnering.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , | Leave a comment

Alnylam Elects Chairman and Board Member

Alnylam Pharmaceuticals, a biopharmaceutical company headquartered in Cambridge, Mass, has named Michael Bonney as Chairman to replace John Clarke who stepped down after 13 years of service. Clarke will remain on the board as a director of the company. Bonny is the current board member and former CEO of Cubist Pharmaceuticals.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , | Leave a comment

Intellia Appoints Caroline Dorsa to Board of Directors

Intellia Therapeutics, a genome editing company based in Cambridge, Massachusetts, has named Caroline Dorsa to its Board of Directors. Her appointment will help advance the company’s mission of developing therapeutics utilizing CRISPR/Cas9 gene-editing technology.Watch Full Movie Online Streaming Online and Download

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , | Leave a comment

Hans Schikan new Chair at InteRNA and Asceneuron

Hans Schikan is former Chief Executive Officer of Prosensa, a biopharmaceutical company focusing on novel RNA modulating treatments for rare diseases like Duchenne muscular dystrophy. Prosensa was listed on NASDAQ (RNA) since June 2013. The company was acquired by BioMarin early 2015 for up to USD 840 million. Before joining Prosensa, Hans worked at Genzyme, including as Vice President for Global Marketing and Strategic Development of Genzyme’s product portfolio for rare genetic diseases. Prior to Genzyme, he worked at Organon, both at corporate level and in country operations which included assignments in Asia and Europe.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , | Leave a comment

Wilson’s Board Gets a New Chairman

Wilson Therapeutics has announced that Andrew Kay has been appointed as Chairman of its Board of Directors. The company’s previous Chairman, Hugh Rienhoff, M.D. will continue to advise the company as a consultant.

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap